%20CO.%2C%20LTD./other/CHANGCHUN_HIGH-TECH_INDUSTRY_GROUP__inq51an.png)
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度独立董事述职报告(李春好) | 2026-04-21 | Chinese | |
| 2025年度内部控制自我评价报告 | 2026-04-21 | Chinese | |
| 2025年度独立董事述职报告(张伟明) | 2026-04-21 | Chinese | |
| 关于召开2025年度及2026年第一季度网上业绩说明会的公告 | 2026-04-21 | Chinese | |
| 关于2025年度计提资产减值准备的公告 | 2026-04-21 | Chinese | |
| 关于2025年度利润分配预案的公告 | 2026-04-21 | Chinese |
Browse filings by year
27 years- 2026 55 filings
- 2025 176 filings
- 2024 162 filings
- 2023 131 filings
- 2022 139 filings
- 2021 152 filings
- 2020 157 filings
- 2019 238 filings
- 2018 124 filings
- 2017 95 filings
- 2016 102 filings
- 2015 122 filings
- 2014 98 filings
- 2013 75 filings
- 2012 80 filings
- 2011 46 filings
- 2010 57 filings
- 2009 47 filings
- 2008 33 filings
- 2007 42 filings
- 2006 48 filings
- 2005 26 filings
- 2004 29 filings
- 2003 27 filings
- 2002 17 filings
- 2001 7 filings
- 1996 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 43002258 | 2025年度独立董事述职报告(李春好) | 2026-04-21 | Chinese | ||
| 43002227 | 2025年度内部控制自我评价报告 | 2026-04-21 | Chinese | ||
| 43002222 | 2025年度独立董事述职报告(张伟明) | 2026-04-21 | Chinese | ||
| 43002179 | 关于召开2025年度及2026年第一季度网上业绩说明会的公告 | 2026-04-21 | Chinese | ||
| 43002153 | 关于2025年度计提资产减值准备的公告 | 2026-04-21 | Chinese | ||
| 43002147 | 关于2025年度利润分配预案的公告 | 2026-04-21 | Chinese | ||
| 43002121 | 关于“质量回报双提升”行动方案的进展公告 | 2026-04-21 | Chinese | ||
| 43002117 | 关于会计政策变更的公告 | 2026-04-21 | Chinese | ||
| 43002082 | 2025年年度审计报告 | 2026-04-21 | Chinese | ||
| 43001959 | 2025年年度报告摘要 | 2026-04-21 | Chinese | ||
| 43001956 | 董事会审计委员会对会计师事务所2025年度履职情况评估及履行监督职责情况的报告 | 2026-04-21 | Chinese | ||
| 43001949 | 2025年度董事会工作报告 | 2026-04-21 | Chinese | ||
| 43001919 | 2025年度独立董事述职报告(张春颖) | 2026-04-21 | Chinese | ||
| 43001884 | 关于2026年度对外捐赠额度预计的公告 | 2026-04-21 | Chinese | ||
| 43001855 | 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-04-21 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53737/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53737 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53737 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53737 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53737}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. (id: 53737)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.